Effect of neuropeptides and monoamines on lymphocyte activation

High levels of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor mRNA expression in primary and tumor lymphoid cells

Neuropeptides exert a variety of putative immunomodulatory actions. Despite the molecular cloning of multiple forms of receptors for several neuropeptides with putative immunomodulatory effects, including vasoactive intestinal peptide (VIP), the related peptide pituitary adenylate cyclase-activating peptide (PACAP), the opiate peptides, tachykinins, somatostatin and corticotropin-releasing factor, it has not been reported that any of the receptor genes are expressed at significant levels in cells of the immune system. The low level of expression of these receptors and lack of knowledge concerning receptor subtype has impeded progress in understanding how neuropeptides regulate immune function. For example, it is not understood why VIP produces immunomodulatory effects at concentrations far below its receptor-binding affinity. Receptors for VIP and PACAP have recently been cloned. We show here by Northern blot analysis that the VIP/PACAP1 receptor mRNA is present in total RNA prepared from mouse spleen B- and T-lymphocytes. The VIP/PACAP1 receptor mRNA was also present in human peripheral blood lymphocytes, and in a B-lymphocyte and a myelocytic cell line. The mRNA for a second form of the receptor, the VIP/PACAP2 receptor, was not expressed at detectable levels in normal cells, but was detected in several human T-cell lines and a murine mast cell line. The results indicate that VIP/PACAP1 and perhaps VIP/PACAP2 receptors mediate the diverse effects of VIP and PACAP on immune cells.

Central nervous system-immune system interactions: psychoneuroendocrinology of stress and its immune consequences

Psychoneuroimmunology is a relatively new discipline which deals with CNS-immune system interactions. The evidence for such interactions was reviewed, as was the neuroendocrinologic response to stress. Recent evidence indicates that the behavioral, nervous system, and neuroendocrine responses to stress are mediated by hypothalamic CRF, which acts on both the sympathetic nervous system and the HPA axis, resulting in increased levels of corticosteroids, catecholamines, and certain opiates, substances which are generally immunosuppressive. Concentrations of growth hormone and prolactin, which are immunoenhancing, are elevated early during the response to stress but are later suppressed. Although several other neuromediators may also be released with stress, the net effect of a variety of acute stressors is down regulation of the immune system function. In the following minireview, I consider whether stress alters the resistance of the host to infection as well as the immunomodulatory effects of released immune system mediators on the brain.

Effect of ergot-alkaloid dihydroergosine on the immune reaction and plasma corticosterone in rats

Ergot-alkaloid dihydroergosine, a potential antidepressive and anxiolytic drug, suppressed humoral and cellular immune reaction in rats, if given in a single injection (2-100 mg/kg) 1 hour after immunization. Plasma corticosterone levels were decreased upon assay of the immune response, 5 or 8 days following treatment.

Protecting effects of vasoactive intestinal polypeptide on lymphocytes against metal toxicity

The hormonal neuropeptides calcitonin gene-related peptide (CGRP), cholecystokinin (CCK), neuropeptide Y (NPY) and vasoactive intestinal peptide (VIP), were investigated for a potential protective effect on thymocytes after a toxic dose of nickel sulfate, giving an inhibition of DNA synthesis. There was a statistically significant increase in the synthesis of DNA from the level caused by nickel sulfate, with VIP, 10(-4)-10(-5) mol/l, while the slightly stimulating effects obtained with CGRP, CCK and NPY, were statistically non-significant. This indicates that VIP, at least as pharmacological concentrations, might have protective effects on lymphocytes against metal toxicity.

Circadian analysis of mononuclear cells in the rat following pinealectomy and superior cervical ganglionectomy

The role of the pineal gland and adrenocorticosteroids in circadian rhythmicity of immune function was investigated in Sprague-Dawley rats that either had been pinealectomized (PX) or had undergone superior cervical ganglionectomy (SCGX), which functionally denervates the pineal. For both experiments, conducted between August and October, rats were entrained to a 10-h light:14-h dark cycle and fed ad libitum. The circadian rhythm in monocytes (ANOVA, p less than .01 for Control + Sham + PX samples) tended to parallel that of plasma corticosteroid levels (ANOVA, p less than .01) with the peak during early dark and the nadir at early light. In comparison, suppressor/cytotoxic T cells and B cells tended to be more frequent during early light with minimum levels during early dark (ANOVA, p less than .05 and .01, respectively, for Control + Sham + PX samples). Natural killer (NK) activity in control animals varied significantly (ANOVA, p less than .05) over the light:dark cycle with peak activity during early dark in the SCGX experiment, but was only slightly elevated during late dark in the PX experiment. PX animals exhibited increased frequency of NK cells, but only in samples collected during the day (t test, p less than .05). This effect was not observed in sham-operated PX controls and in SCGX animals. Neither PX nor SCGX had a significant (ANOVA) effect on plasma corticosterone levels. These observations in the rat are consistent with findings in mice and humans that corticosteroids play an important general role in circadian rhythmicity of immune functions. In contrast, the present study suggests that pineal gland influence of immune function(s) is more specific and that pineal gland interaction with NK cells has a circadian component.

Neurohormonal immunoregulation

The immune system may be divided into primary lymphoid organs (bone marrow, bursa of Fabricius, and thymus), which produce mature leukocytes and secondary organs (spleen, lymph nodes, tonsils, Peyer's patches, etc.), which are concerned with specific immune responses. In the primary organs, stem cells proliferate and differentiate into various subsets of polymorphonuclear and mononuclear cells. Evidence is increasing that cell proliferation in the primary lymphoid organs is dependent on pituitary growth hormone (GH) and prolactin (PRL), which control the expression of growth regulatory genes (protooncogenes) such as c-myc and also induce essential growth factors (insulinlike growth factor, thymic and bursal hormones, etc.) and, possibly, their receptors. The adrenocorticotropic hormone-adrenal axis serves as an inhibitory pathway, antagonizing the action of PRL and GH on primary lymphoid tissue. The effect of glucocorticoids is especially forceful on thymocytes through the activation of the genetically programmed suicide pathway. Sex hormones also regulate the primary lymphoid organs, but their mechanism of action remains to be clarified. Thymus-derived feedback signals toward the pituitary gland have already been described. The pituitary gland exerts a similar regulatory influence on mature lymphocytes during their antigen-driven differentiation. PRL or GH is required for primary immune reactions; however, the secondary immune response may be less dependent on these hormones. Once the immune system is primed, antigen itself becomes a primary regulator. Exposure of memory cells to antigen leads to the production of growth factors (interleukins) and to the expression of their receptors. Therefore, antigen appears to fulfill, at this stage, a role that is originally played by GH or PRL in the primary lymphoid organs and, to some extent, also during antigen-driven differentiation. During immune reactions, interleukin-1 and tumor necrosis factor activate the adrenocorticotropic hormoneadrenal axis, which plays an important role in setting upper limits to and terminating responses. Lymphocytes have receptors for and react to numerous hormones, neurotransmitters, and mediators derived from a number of organs and tissues. Therefore, ultimately the reaction of a lymphocyte will be the vector of all positive and negative signals received. A hierarchy and sequential system of signals exists. Primary regulatory signals (competence signals) represent the most powerful regulators (e.g., PRL, GH or antigen) of lymphoid cells. The delivery of a competence signal is the prerequisite for subsequent lymphoproliferation, which is regulated by growth factors that are specific for a certain developmental stage of the lymphoid cell and act sequentially. Hormonal factors that promote growth and differentiation deliver the second regulatory signals. Competence factors and growth and differentiation hormones regulate gene expression in lymphocytes. The third class of signals modulate the function of mature effector cells (e.g., locomotion, secretion, phagocytosis, cytotoxicity). Neuro-transmitters appear to function as secondary signal modulators and tertiary functional regulators.